Harjacek M - Search Results

1

[Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].

Bukovac LT, Vidović M, Lamot L, Perica M, Harjacek M; Croatian Society for Rheumatology. Bukovac LT, et al. Among authors: harjacek m. Reumatizam. 2013;60(1):57-66. Reumatizam. 2013. PMID: 24003687 Croatian.

2

[JUVENILE SPONDYLOARTHRITIS].

Lamot L, Harjaček M. Lamot L, et al. Among authors: harjacek m. Reumatizam. 2016;63 Suppl 1:59-65. Reumatizam. 2016. PMID: 29624303 Review. Croatian.

3

The 'head-to-head' comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis.

Lamot L, Bukovac LT, Vidovic M, Frleta M, Harjacek M. Lamot L, et al. Among authors: harjacek m. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):131-9. Epub 2011 Feb 23. Clin Exp Rheumatol. 2011. PMID: 21345300

4

[Juvenile dermatomyositis].

Bukovac LT, Perica M, Vidović M, Lamot L, Harjacek M. Bukovac LT, et al. Among authors: harjacek m. Reumatizam. 2012;59(2):63-72. Reumatizam. 2012. PMID: 23745459 Review. Croatian.

5

Single nucleotide polymorphism of toll-like receptor 4 (TLR4) is associated with juvenile spondyloarthritis in Croatian population.

Perica M, Vidović M, Lamot L, Bukovac LT, Kapitanović S, Perić M, Barbić J, Harjaček M. Perica M, et al. Among authors: harjacek m. Clin Rheumatol. 2015 Dec;34(12):2079-86. doi: 10.1007/s10067-015-2952-8. Epub 2015 Apr 30. Clin Rheumatol. 2015. PMID: 25920454

6

[PATHOGENESIS OF UNDIFFERENTIATED SPONDYLOARTHRITIS].

Lamot L, Vidović M, Perica M, Bukovac LT, Harjacek M. Lamot L, et al. Among authors: harjacek m. Reumatizam. 2015;62(1):20-6. Reumatizam. 2015. PMID: 26891577 Croatian.

7

Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response.

Vidovic M, Lamot L, Lamot M, Harjacek M. Vidovic M, et al. Among authors: harjacek m. Clin Exp Rheumatol. 2018 Jul-Aug;36(4):676-682. Epub 2018 Mar 21. Clin Exp Rheumatol. 2018. PMID: 29600948

8

The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Harjacek M, Lamot L, Lamot M, Vidovic M, Bosak EP, Bukovac LT, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). Harjacek M, et al. Rheumatol Int. 2018 Apr;38(Suppl 1):115-122. doi: 10.1007/s00296-018-3945-0. Epub 2018 Apr 7. Rheumatol Int. 2018. PMID: 29637331 Free PMC article.

9

Beyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndrome.

Vukić V, Smajo A, Vidović M, Vukojević R, Harjaček M, Lamot L. Vukić V, et al. Among authors: harjacek m. BMC Pediatr. 2021 Jan 15;21(1):40. doi: 10.1186/s12887-021-02494-6. BMC Pediatr. 2021. PMID: 33451288 Free PMC article.

10

Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.

Lamot L, Borovecki F, Tambic Bukovac L, Vidovic M, Perica M, Gotovac K, Harjacek M. Lamot L, et al. Among authors: harjacek m. PLoS One. 2014 Dec 15;9(12):e115416. doi: 10.1371/journal.pone.0115416. eCollection 2014. PLoS One. 2014. PMID: 25506924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters